The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarshalls Regulatory News (MSLH)

Share Price Information for Marshalls (MSLH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 257.50
Bid: 257.00
Ask: 258.00
Change: 1.00 (0.39%)
Spread: 1.00 (0.389%)
Open: 254.00
High: 258.00
Low: 252.50
Prev. Close: 256.50
MSLH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

31 Mar 2017 07:00

RNS Number : 0931B
Marshalls PLC
31 March 2017
 

 

31 March 2017

 

Directorate Changes

 

Marshalls plc ("Marshalls" or "the Company") is pleased to announce the appointment of Graham Prothero to the Board as a non-executive director, which will take effect immediately after the Annual General Meeting ("AGM") of Marshalls plc on 10 May 2017.

 

Mark Edwards, non-executive Director and Chair of the Audit Committee, who has served on the Board since May 2010, has announced his intention to retire from the Board following the close of the AGM on 10 May 2017. It is expected that Graham Prothero will succeed Mark Edwards as Chair of the Audit Committee upon Mark's retirement.

 

Graham Prothero is a Chartered Accountant and is an Executive Director and Group Chief Financial Officer of Galliford Try plc, the industry-leading FTSE 250 housebuilding, regeneration and construction group. He is also Non-Executive Deputy Chair of the Jigsaw Trust, a charitable trust. Prior to joining Galliford Try plc in 2013, he was Group Finance Director at leading property developer Development Securities PLC (now U+I), having previously held senior finance positions at Taylor Woodrow, the FTSE 100 listed housebuilder, and at Blue Circle Industries plc. Graham also spent 7 years as a partner in the Real Estate, Hospitality and Construction Group of Ernst & Young LLP. He brings current and relevant financial experience in the construction and building materials sector, as well as wider experience in an advisory professional capacity in relation to businesses operating in construction, real estate and other sectors.

 

The recruitment of Graham Prothero to succeed Mark Edwards takes place in line with the Company's Board development and succession planning strategy to regularly refresh the skills and experience around the Board table, and followed a formal, rigorous and objective process led by the Nomination Committee with the help of external consultants Lygon.

 

Andrew Allner, Chairman of Marshalls, commented: "I am delighted that Graham Prothero will be joining the Board as a non-executive director to succeed Mark Edwards. He brings broad financial and relevant sector experience and will be a valuable addition to the Board. I would also like to express our thanks to Mark Edwards, who is stepping down after 7 years' service on the Marshalls Board and as Chair of the Audit Committee. Mark's contribution to the Board and the Company is greatly appreciated".

 

Enquiries:

Andrew Allner - Chairman (Tel: 01422 314777)

Martyn Coffey - Chief Executive (Tel: 01422 314777)

Andrew Jaques / James White / Charlie Barker - MHP (Tel: 0203 128 8540)

 

Additional information:

Graham Prothero is independent for the purposes of the UK Corporate Governance Code This announcement includes the information required by Listing Rules 9.6.11 to 9.6.13, and there is no information to report under Listing Rule 9.6.13 (2) - (6) inclusive.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAURRBRBVAOOAR
Date   Source Headline
19th Apr 20248:51 amRNSHolding(s) in Company
10th Apr 20242:03 pmRNSAnnual Financial Report
22nd Mar 202412:40 pmRNSDirector/PDMR Shareholding
19th Mar 20242:00 pmRNSDirector/PDMR Shareholding
19th Mar 20241:59 pmRNSDirector/PDMR Shareholding
19th Mar 20241:57 pmRNSDirector/PDMR Shareholding
19th Mar 20241:56 pmRNSDirector/PDMR Shareholding
18th Mar 202412:07 pmRNSDirector/PDMR Shareholding
18th Mar 20247:00 amRNSFinal Results
26th Feb 202410:36 amRNSDirector/PDMR Shareholding
15th Feb 20249:49 amRNSHolding(s) in Company
1st Feb 202411:59 amRNSHolding(s) in Company
31st Jan 20241:17 pmRNSHolding(s) in Company
18th Jan 20247:00 amRNSTrading Statement
21st Dec 20239:36 amRNSHolding(s) in Company
6th Dec 20237:00 amRNSCEO Succession
1st Dec 20233:08 pmRNSHolding(s) in Company
28th Nov 20233:17 pmRNSHolding(s) in Company
7th Nov 20231:47 pmRNSStatement re 2023 AGM Remuneration Report Vote
3rd Nov 202310:38 amRNSDirector Declaration
27th Oct 20239:56 amRNSHolding(s) in Company
23rd Oct 20234:14 pmRNSHolding(s) in Company
20th Oct 202310:36 amRNSHolding(s) in Company
18th Oct 20234:04 pmRNSHolding(s) in Company
18th Oct 20234:02 pmRNSHolding(s) in Company
18th Oct 202312:38 pmRNSDirector/PDMR Shareholding
18th Oct 20237:00 amRNSTrading Statement
17th Oct 202311:52 amRNSHolding(s) in Company
6th Oct 20233:39 pmRNSHolding(s) in Company
4th Oct 20233:41 pmRNSDirector/PDMR Shareholding
2nd Oct 20231:08 pmRNSHolding(s) in Company
17th Aug 20237:00 amRNSDirector/PDMR Shareholding
17th Aug 20237:00 amRNSDirector/PDMR Shareholding
16th Aug 20237:00 amRNSHalf-year Report
2nd Aug 20238:49 amRNSHolding(s) in Company
31st Jul 20237:00 amRNSTrading Statement
21st Jul 202311:25 amRNSDirector Declaration
19th Jul 202312:09 pmRNSDirector Declaration
13th Jul 20234:44 pmRNSDirector/PDMR Shareholding
13th Jul 20234:42 pmRNSDirector/PDMR Shareholding
13th Jul 20234:40 pmRNSDirector/PDMR Shareholding
26th Jun 20234:45 pmRNSDirector/PDMR Shareholding
26th Jun 20234:42 pmRNSDirector/PDMR Shareholding
21st Jun 20232:13 pmRNSHolding(s) in Company
25th May 20233:05 pmRNSHolding(s) in Company
12th May 20239:13 amRNSHolding(s) in Company
10th May 20234:48 pmRNSResult of AGM
10th May 202312:53 pmRNSResult of AGM
9th May 20231:06 pmRNSDirector/PDMR Shareholding
9th May 202312:31 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.